Abstract
Incomplete Kawasaki disease (IKD) and atypical Kawasaki disease (AKD) represent rare conditions. Two cases of unexpected or sudden infant death are reported. The diagnosis for a 3-month-old girl was determined by echocardiography, and the child unexpectedly died despite appropriate treatment, whereas autopsy determined the diagnosis of AKD for a 4-month-old boy. In both patients, giant coronary artery aneurysms with thrombosis and vasculitis, myocarditis, and coagulative necrosis were shown at autopsy. These rare forms of IKD and AKD carry a poor prognosis and represent a paradox between the severe cardiovascular damage and the clinical presentation that mimics common and usually self-limiting exanthematic infectious disease in infancy.
References
Choueiter NF, Olson AK, Shen DD, Portman MA (2010) Prospective open-label trial of etanercept as adjunctive therapy for Kawasaki disease. J Pediatr 157:960–966
Diana MC, Villa G, Gattorno M, Ottonello G, Costabel S, Savioli C, DiPietro P (2006) Sudden death in an infant revealing atypical Kawasaki disease. Pediatr Emerg Care 22:35–37
Furuno K, Yuge T, Kusuhara K, Takada H, Nishio H, Khajoee V, Ohno T, Hara T (2004) CD25+ CD4+ regulatory T cells in patients with Kawasaki disease. J Pediatr 145:385–390
Lie JT, Sanders JA (1997) Kawasaki disease: sudden death in early infancy from accelerated late sequelae of coronary artery aneurysms. Cardiovasc Pathol 6:175–178
Manlhiot C, Yeung RS, Clarizia NA, Chahal N, McCrindle BW (2009) Kawasaki disease at the extremes of the age spectrum. Pediatrics 124:410–415
Maresi E, Passantino R, Midulla R, Ottoveggio G, Orlando E, Becchina G, Meschis L, Amato G (2001) Sudden infant death caused by a ruptured coronary aneurysm during acute phase of atypical Kawasaki disease. Hum Pathol 32:1407–1409
Newburger JW, Sleeper RA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP, Pediatric Heart Network Investigators (2007) Randomized trial of pulsed corticosteroids therapy for primary treatment of Kawasaki disease. N Engl J Med 356:663–675
Pannaraj PS, Turner CL, Bastian JF, Burns JC (2004) Failure to diagnose Kawasaki disease at the extremes of the pediatric age range. Pediatr Infect Dis J 23:789–791
Pucci A, Martino S, Celeste A, Linari A, Tibaldi M, Camosso E, Muscio M, Barattia G, Riva C, Bartoloni G (2008) Angiogenesis, tumor necrosis factor-alpha, and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease. Cardiovasc Pathol 17:186–189
Rowley AH (2002) Incomplete (atypical) Kawasaki disease. Pediatr Infect Dis J 21:563–565
Vanlieferinghen PH, Brunet F, Beaufrère AM, Borderon C, Déchelotte P (2002) Sudden unexpected death in an infant due to a ruptured coronary aneurysm revealing Kawasaki disease. Arch de Pédiatrie 9:1248–1251
Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS (2004) Infliximab as a novel therapy for refractory Kawasaki disease. J Rheumatol 31:808–810
Yellen ES, Gauvreau K, Takahashi M, Burns JC, Shulman S, Baker AL, Innocentini N, Zambetti C, Pancheri JM, Ostrow A, Frazer JR, Sundel RP, Fulton DR, Newburger JW (2010) Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics 125:e234–e241
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pucci, A., Martino, S., Tibaldi, M. et al. Incomplete and Atypical Kawasaki Disease: A Clinicopathologic Paradox at High Risk of Sudden and Unexpected Infant Death. Pediatr Cardiol 33, 802–805 (2012). https://doi.org/10.1007/s00246-012-0186-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-012-0186-y